SG11201501534QA - Fluorescence-labelled fatty acids and uses thereof - Google Patents

Fluorescence-labelled fatty acids and uses thereof

Info

Publication number
SG11201501534QA
SG11201501534QA SG11201501534QA SG11201501534QA SG11201501534QA SG 11201501534Q A SG11201501534Q A SG 11201501534QA SG 11201501534Q A SG11201501534Q A SG 11201501534QA SG 11201501534Q A SG11201501534Q A SG 11201501534QA SG 11201501534Q A SG11201501534Q A SG 11201501534QA
Authority
SG
Singapore
Prior art keywords
fluorescence
fatty acids
labelled fatty
labelled
acids
Prior art date
Application number
SG11201501534QA
Inventor
Stefan Petry
Marc Nazaré
Thorsten Schmidt
Hans Matter
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of SG11201501534QA publication Critical patent/SG11201501534QA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00Assays, e.g. immunoassays or enzyme assays, involving lipids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11201501534QA 2012-09-06 2013-09-04 Fluorescence-labelled fatty acids and uses thereof SG11201501534QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12306069 2012-09-06
PCT/EP2013/068275 WO2014037394A1 (en) 2012-09-06 2013-09-04 Fluorescence-labelled fatty acids and uses thereof

Publications (1)

Publication Number Publication Date
SG11201501534QA true SG11201501534QA (en) 2015-03-30

Family

ID=46963638

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201501534QA SG11201501534QA (en) 2012-09-06 2013-09-04 Fluorescence-labelled fatty acids and uses thereof

Country Status (6)

Country Link
US (1) US20150285812A1 (en)
AU (1) AU2013311718A1 (en)
CA (1) CA2883390A1 (en)
MX (1) MX2015002989A (en)
SG (1) SG11201501534QA (en)
WO (1) WO2014037394A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105295896B (en) * 2015-09-11 2017-12-29 浙江大学 The capsaicine fluorescence probe and its synthetic method of a kind of specific marker and application
CN105203513B (en) * 2015-09-21 2018-01-12 苏州大学 Application of the red sulfonamido acetic acid as enhanced mercury ion fluorescence probe

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060228764A1 (en) * 2003-06-27 2006-10-12 Hussain M M Fluoresence assay for mtp activity

Also Published As

Publication number Publication date
CA2883390A1 (en) 2014-03-13
US20150285812A1 (en) 2015-10-08
AU2013311718A1 (en) 2015-03-19
MX2015002989A (en) 2015-06-17
WO2014037394A1 (en) 2014-03-13

Similar Documents

Publication Publication Date Title
HK1209413A1 (en) Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof 5--2-
HK1199023A1 (en) Substituted benzothienylpyrrolotriazines and uses thereof
IL237156B (en) Microcapsule compositions and methods
HK1200822A1 (en) Substituted dipyridylamines and uses thereof
HK1211282A1 (en) Substituted aminoindane and aminotetralincarboxylic acids and use thereof
HK1210949A1 (en) Combinations and uses thereof
ZA201501124B (en) Trans-clomiphene formulations and uses thereof
EP2809317A4 (en) Fatty acids as anti-inflammatory agents
EP2887928A4 (en) Retinoids and use thereof
ZA201409124B (en) Reassortant btv and ahsv vaccines
HK1210809A1 (en) Beta-hexosyl-transferases and uses thereof
EP2874641A4 (en) Glutathione-elevating compositions and uses thereof
EP2822578A4 (en) Tissue constructs and uses thereof
SG11201501534QA (en) Fluorescence-labelled fatty acids and uses thereof
HK1212164A1 (en) Beta-hydroxy-beta-methylbutryic acid- containing compositions and uses thereof ---
ZA201502159B (en) Mycobacterial thiolperoxidase and its use
LT2830587T (en) Dermo-protective and dermo-balancing composition
AP2015008228A0 (en) Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof
GB201208974D0 (en) Improvements in the manufacture of fatty acids
GB201206431D0 (en) Methods and compostitionsfor identifying nucliec acids
GB201222541D0 (en) Kiddibidet and pottibidet
EP2881111A4 (en) Immune cell activation inhibitor and use thereof
IL218974A0 (en) Conaction bitwen coutch and playels
GB201202021D0 (en) Co-sleeper and breastfeeder